BRCA2 and prostate carcinoma: As such, we decided to generate CRISPR-mediated BRCA1 or BRCA2 gene KOs in the ovarian adenocarcinoma cell line SKOV3 and the prostate carcinoma DU145 cell line (Supplementary Fig. S1A and Materials and Methods).